International Journal of Surgical Pathology · 2005 · 104 citations · 34 references
MedicineOncologyPathologyNeoplasiaSalivary Gland DisordersTumor PathologyImmunohistochemistrySalivary Gland CancerSalivary Gland MalignanciesSalivary GlandsTumor MarkersTumor MorphologyAdenoid Cystic Carcinoma CytologyAdenomatoid TumorImmunohistochemistry Of Salivary GlandsLuminal CellsMalignant Salivary Gland NeoplasmsMyoepithelial CarcinomaSalivary Gland HistochemistrySalivary Gland Tumor Cytology
We compared the immunoexpression of 5 myoepithelial cell (MEC) markers (alpha-smooth-muscle actin, calponin, h-caldesmon, vimentin, and S-100-protein) using 16 pleomorphic adenomas (PA), 15 adenoid cystic carcinomas (ACC), and 3 epithelial-myoepithelial carcinomas (EMC) of salivary glands. The alpha-smooth-muscle actin was useful for identification of MECs, especially in cribriform and tubular ACC, followed by EMC. Calponin was similar to alpha-smooth-muscle actin, except for polygonal and plasmacytoid cells of PA and for solid ACC, which showed alpha-smooth-muscle actin negative and calponin positive. H-caldesmon was negative. Vimentin immunostained all MEC types, and was negative in luminal cells. S-100 protein was expressed both in the nuclei and cytoplasm of MECs and luminal cells, especially in PA. The best way to identify MEC is using alpha-smooth-muscle actin or calponin, plus vimentin, since in tumors MECs are hardly ever fully differentiated.
34
Myoepithelial Carcinoma of the Salivary Glands
Adnan T. Savera, Andrew Sloman, Andrew G. Huvos et al. · The American Journal of Surgical Pathology · 2000 · 405 citations
Salivary gland malignant myoepithelioma
Toshitaka Nagao, Isamu Sugano, Yasuo Ishida et al. · Cancer · 1998 · 286 citations · Full text